Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | IKK16 | 2.0 | uM | 2 | MCP3 | 20.5 | 66 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | MCP3 | 18.0 | 75 | ||||
RA2159 | 2 | MCP3 | 19.0 | 55 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | MCP3 | 22.0 | 54 | ||||
N2645 | 2 | MCP3 | 22.0 | 59 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | MCP3 | 21.0 | 47 | ||||
RA2708 | 2 | MCP3 | 22.0 | 49 | |||||||
0 | MCP3 | 20.0 | 43 | ||||||||
0 | MCP3 | 22.0 | 71 | ||||||||
0 | MCP3 | 18.0 | 55 | ||||||||
0 | MCP3 | 13.5 | 62 | ||||||||
0 | MCP3 | 18.5 | 44 | ||||||||
0 | MCP3 | 18.5 | 38 | ||||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MCP3 | 20.0 | 81 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | MCP3 | 18.0 | 97 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MCP3 | 18.0 | 96 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | MCP3 | 20.0 | 101 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MCP3 | 18.0 | 88 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | MCP3 | 18.0 | 92 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MCP3 | 16.0 | 91 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | MCP3 | 18.0 | 77 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | MCP3 | 18.0 | 85 | ||||
RA1869 | 3 | MCP3 | 19.0 | 73 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | MCP3 | 19.0 | 55 | ||||
N2759 | 3 | MCP3 | 18.0 | 75 |